Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bio Leg: Advancing Mobility

NCT: NCT07613502 · NOT_YET_RECRUITING

NCT IDNCT07613502
StatusNOT_YET_RECRUITING
Start Date2026-06-01
Completion2028-07

Brief Summary

Following transfemoral amputation, regaining functional mobility, particularly the ability to navigate curbs, ramps, long distances, and the ability to stand is challenging and often unattainable. Use of advanced prosthetic limb technology can dramatically influence mobility outcomes. The purpose of this study is to compare walking function in individuals with transfemoral amputations who are current users of the C-leg (current clinical standard) to function achieved when using the Bio Leg powered micro-processor prosthetic knee.

Frequently Asked Questions

What is Bio Leg: Advancing Mobility?

Bio Leg: Advancing Mobility is a clinical trial registered under NCT07613502. Current status: NOT_YET_RECRUITING.

What is the status of NCT07613502?

The current status of NCT07613502 (Bio Leg: Advancing Mobility) is: NOT_YET_RECRUITING.

When did Bio Leg: Advancing Mobility start?

Bio Leg: Advancing Mobility started on 2026-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.